Latest News & Features
Refine Search
Big Pharma
 In November, the UK Supreme Court ruled that Warner-Lambert’s patent for a second medical use of pregabalin for the treatment of pain is invalid for insufficiency of disclosure. Sheena Linehan of Potter Clarkson explores the lessons for patent drafting.   28 November 2018 
Americas
 California-based FlexStent accused healthcare company Abbott Laboratories of infringing a stent patent earlier this week, with the filing of a lawsuit at the US District Court for the Central District of California.   28 November 2018 
Americas
 The US Food and Drug Administration is set to change the way that medical devices are approved, after 42 years.   27 November 2018 
Biotechnology
 Despite the importance of IP rights to biotech and biopharma innovation, recent decisions and new policies are weakening and reducing the scope of IP-based incentives, according to a report.   27 November 2018 
Asia-Pacific
 India-based drug company Sun Pharma has made further inroads into the Japanese market with the planned acquisition of Pola Pharma.   26 November 2018 
Big Pharma
 The EU General Court dismissed Canada-based Endoceutics’ trademark appeal in a win for medical technology company Merck KGaA on Thursday, November 22.   26 November 2018 
Asia-Pacific
 Scientists have urged policymakers to implement a regulatory framework governing the use of CRISPR technology in humans, following reports that a Chinese scientist has successfully created ‘edited’ twins.   26 November 2018 
Biotechnology
 The global CRISPR technology market is expected to reach $1.72 million in value by 2023, up from 2018’s predicted figure of $562 million, according to a report released this month.   23 November 2018 
Americas
 Saul Ewing Arnstein & Lehr has strengthened its Boston office with the addition of two life sciences partners from Hamilton, Brook, Smith & Reynolds.   23 November 2018 
Americas
 The US Court of Appeals for the Federal Circuit vacated a preliminary injunction against India-based Dr Reddy’s earlier this week, in a blow for addiction treatment drug producer Indivior.   22 November 2018 


